| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2005-07-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ca97200cd30515bfd2ac7074c229699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cea9c3484d28d4465e59561fbb18dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f925427de89d93230584f6986224a2a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b79a0a85264a7bca91abefbd2e2969f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88b23627e90c1957c30a829b3c10d6c7 |
| publicationDate |
2011-04-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-552405-A |
| titleOfInvention |
Pyrrolidine containing antiviral compounds |
| abstract |
Disclosed is a phosphorus containing pyrrolidinyl compound of formula I where the substituents are as disclosed in the specification. Also disclosed is a pharmaceutical composition containing a compound of formula I and the use of a compound of formula I for the manufacture of a medicament for treating hepatitis C or a hepatitis C associated disorder. |
| priorityDate |
2004-07-16^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |